Clinical Trial Update: Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy

View source ↗

Summary

This clinical trial update describes a study led by Imperial College London to define the genetics, biomarkers, and outcomes for dilated cardiomyopathy. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Snippet

Sponsor: Imperial College London | Conditions: Dilated Cardiomyopathy, Cardiovascular Diseases | Status: ACTIVE_NOT_RECRUITING